Dimensional Fund Advisors LP Supernus Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

  • $418 Billion
  • Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 3,021,207 shares of SUPN stock, worth $148 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,021,207
Previous 2,903,727 4.05%
Holding current value
$148 Million
Previous $95.1 Million 0.14%
% of portfolio
0.02%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$30.29 - $33.43 $3.56 Million - $3.93 Million
117,480 Added 4.05%
3,021,207 $95.2 Million
Q1 2025

May 13, 2025
BUY
$31.17 - $40.0 $784,922 - $1.01 Million
25,182 Added 0.87%
2,903,727 $95.1 Million
Q4 2024

Feb 13, 2025
SELL
$31.89 - $37.83 $126,284 - $149,806
-3,960 Reduced 0.14%
2,878,545 $104 Million
Q3 2024

Nov 07, 2024
BUY
$25.77 - $35.16 $402,475 - $549,128
15,618 Added 0.54%
2,882,505 $89.9 Million
Q2 2024

Aug 09, 2024
BUY
$25.99 - $33.85 $8.06 Million - $10.5 Million
309,966 Added 12.12%
2,866,887 $76.7 Million
Q1 2024

May 10, 2024
BUY
$27.11 - $35.17 $2.73 Million - $3.54 Million
100,552 Added 4.09%
2,556,921 $87.2 Million
Q4 2023

Feb 07, 2024
BUY
$22.72 - $29.68 $3.22 Million - $4.2 Million
141,586 Added 6.12%
2,456,369 $71.1 Million
Q3 2023

Nov 09, 2023
SELL
$27.57 - $32.91 $3.2 Million - $3.82 Million
-116,133 Reduced 4.78%
2,314,783 $63.8 Million
Q2 2023

Aug 09, 2023
BUY
$29.91 - $38.73 $1.19 Million - $1.54 Million
39,650 Added 1.66%
2,430,916 $73.1 Million
Q1 2023

May 12, 2023
BUY
$34.93 - $42.03 $276,680 - $332,919
7,921 Added 0.33%
2,391,266 $86.6 Million
Q4 2022

Feb 09, 2023
BUY
$31.09 - $37.88 $3.51 Million - $4.28 Million
112,865 Added 4.97%
2,383,345 $85 Million
Q3 2022

Nov 10, 2022
BUY
$28.79 - $35.41 $902,710 - $1.11 Million
31,355 Added 1.4%
2,270,480 $76.9 Million
Q2 2022

Aug 12, 2022
BUY
$25.33 - $34.25 $451,000 - $609,821
17,805 Added 0.8%
2,239,125 $64.8 Million
Q1 2022

May 13, 2022
SELL
$28.51 - $32.9 $550,271 - $635,002
-19,301 Reduced 0.86%
2,221,320 $71.8 Million
Q4 2021

Feb 09, 2022
SELL
$26.37 - $34.22 $907,919 - $1.18 Million
-34,430 Reduced 1.51%
2,240,621 $65.3 Million
Q3 2021

Nov 12, 2021
SELL
$23.54 - $31.39 $26,694 - $35,596
-1,134 Reduced 0.05%
2,275,051 $60.7 Million
Q2 2021

Aug 12, 2021
BUY
$26.72 - $33.19 $3.85 Million - $4.78 Million
144,093 Added 6.76%
2,276,185 $70.1 Million
Q1 2021

May 14, 2021
BUY
$24.15 - $31.45 $4.76 Million - $6.2 Million
197,229 Added 10.19%
2,132,092 $55.8 Million
Q4 2020

Feb 25, 2021
BUY
$17.7 - $25.81 $34.2 Million - $49.9 Million
1,934,863 New
1,934,863 $48.7 Million

Others Institutions Holding SUPN

# of Institutions
315
Shares Held
61.7M
Call Options Held
18.4K
Put Options Held
0
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.62B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email